Omniab, INC. (OABIW) — 10-Q Filings
All 10-Q filings from Omniab, INC.. Browse 4 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (4)
-
OmniAb's Revenue Plunges 34% Amidst Persistent Losses
— Nov 4, 2025 Risk: high
OmniAb, Inc. (OABIW) reported a significant decline in total revenue for the nine months ended September 30, 2025, falling to $10.29 million from $15.59 million -
OmniAb Revenue Soars 110% in Q2 on Strong Licensing Growth
— Aug 6, 2025 Risk: medium
OmniAb, Inc. (OABIW) reported a significant increase in total revenue for the three and six months ended June 30, 2025. Total revenue for Q2 2025 surged to $10. -
OmniAb, Inc. Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
OmniAb, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly Avista Public Acquisition Corp. II, reported financial results for t -
OmniAb, Inc. Files Q2 2024 10-Q with Revenue Data
— Aug 8, 2024 Risk: medium
OmniAb, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly Avista Public Acquisition Corp. II, is focused on commercial physical & b
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX